SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000921895-19-002436
Filing Date
2019-09-19
Accepted
2019-09-19 17:23:06
Documents
4

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO THE SCHEDULE 13D sc13da312274002_09192019.htm SC 13D/A 451286
2 PRESS RELEASE, DATED SEPTEMBER 18, 2019 ex991to13da312274002_091919.htm EX-99.1 34982
3 JOINT FILING AND SOLICITATION AGREEMENT ex992to13da312274002_091919.htm EX-99.2 27313
4 POWERS OF ATTORNEY ex993to13da312274002_091919.htm EX-99.3 61652
  Complete submission text file 0000921895-19-002436.txt   576749
Mailing Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007 646-975-2500
PROGENICS PHARMACEUTICALS INC (Subject) CIK: 0000835887 (see all company filings)

IRS No.: 133379479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-52343 | Film No.: 191102305
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1055B POWERS PLACE SUITE 810 ALPHARETTA GA 30009
Business Address 5348 VEGAS DR., UNIT 733 LAS VEGAS NV 89108 404-664-3629
Altiva Management Inc. (Filed by) CIK: 0001772491 (see all company filings)

IRS No.: 821992901 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A